Liquid Biopsy: Transforming Cancer Diagnostics Through Circulating Biomarkers
Explore how liquid biopsy technologies are revolutionizing cancer detection and monitoring through analysis of circulating tumor DNA, RNA, and proteins.
Liquid biopsy represents a revolutionary approach to cancer diagnostics, offering a minimally invasive alternative to traditional tissue biopsies. By analyzing circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), and other biomarkers in blood samples, liquid biopsy enables real-time monitoring of cancer progression and treatment response.
Full article content coming soon...